TITLE

Opinion: ImClone/UCB: tapping into a rich vein

PUB. DATE
October 2005
SOURCE
PharmaWatch: Cancer;Oct2005, Vol. 4 Issue 10, p11
SOURCE TYPE
Market Research Report
DOC. TYPE
Article
ABSTRACT
Focuses on a partnership between ImClone Systems Inc. and UCB Group Ltd. to co-develop an early-stage cancer drug. Terms of the alliance; Renewal of interest in angiogenesis inhibitors; Process of drug approval.
ACCESSION #
18633859

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics